SAN || FDA & CDC

FDA panel backs injectable treatment for chin fat

Posted on: 09/03/2015 - 21:03

SILVER SPRING, MD – A less-invasive alternative to liposuction and other cosmetic treatments for submental fat will likely become available in the U... More »

Field of Interest: Dermatology

Type: News Item

Secukinumab earns FDA approval for plaque psoriasis

Posted on: 21/01/2015 - 21:38

The U.S. Food and Drug Administration has approved secukinumab for the treatment of moderate to severe plaque psoriasis in adults. The injectable interleukin-17A inhibitor is indicated for...

Field of Interest: Dermatology

Type: News Item

FDA approves topical ivermectin for rosacea

Posted on: 23/12/2014 - 19:36

The Food and Drug Administration has approved a topical formulation of ivermectin for the once-daily topical treatment of inflammatory lesions related to rosacea. The drug will be marketed as...

Field of Interest: Dermatology

Type: News Item

FDA panel unanimously supports secukinumab approval for psoriasis

Posted on: 20/10/2014 - 23:15

SILVER SPRING, MD. – The human monoclonal antibody secukinumab is expected to be the first biologic that targets interleukin-17A to be approved by the agency for treating psoriasis, with a Food and...

Field of Interest: Dermatology

Type: News Item

Apremilast approval expanded to include plaque psoriasis

Posted on: 24/09/2014 - 20:48

The oral phosphodiesterase-4 inhibitor apremilast is now indicated for the treatment of moderate to severe plaque psoriasis. On Sept. 23, the manufacturer, Celgene, announced that the Food and Drug...

Field of Interest: Dermatology

Type: News Item

FDA advisers want more data on sunscreen safety

Posted on: 05/09/2014 - 20:40

SILVER SPRING, MD. – The widespread and long-term use of sunscreens demands that manufacturers provide more long-term safety data and information on how the active ingredients affect the health of...

Field of Interest: Oncology

Type: News Item

FDA advisers want more data on sunscreen safety

Posted on: 05/09/2014 - 20:40

Field of Interest: Dermatology

Type: News Item

FDA approves oritavancin for skin infections

Posted on: 07/08/2014 - 18:35

The Food and Drug Administration has approved the injectable antibiotic oritavancin (Orbactiv) to treat adults with acute bacterial skin and skin structure infections that might be caused by...

Field of Interest: Dermatology

Type: News Item

OTC topical acne meds can cause severe reactions

Posted on: 25/06/2014 - 20:55

The Food and Drug Administration says that some over-the-counter acne products can cause severe hypersensitivity or allergic reactions and is warning consumers to discontinue use immediately and seek...

Field of Interest: Dermatology

Type: News Item

FDA approves tedizolid for acute bacterial skin infections

Posted on: 21/06/2014 - 00:10

Tedizolid, an oxazolidinone antibacterial drug, has been approved as an intravenous and oral treatment for acute bacterial skin and skin structure infections caused by gram positive bacteria, the...

Field of Interest: Dermatology

Type: News Item

FDA panel backs injectable treatment for chin fat

Secukinumab earns FDA approval for plaque psoriasis

FDA approves topical ivermectin for rosacea

FDA panel unanimously supports secukinumab approval for psoriasis

Apremilast approval expanded to include plaque psoriasis

FDA advisers want more data on sunscreen safety

FDA advisers want more data on sunscreen safety

FDA approves oritavancin for skin infections

OTC topical acne meds can cause severe reactions

FDA approves tedizolid for acute bacterial skin infections

Newsletters

Latest Newsletters

You are here

SAN || FDA & CDC

Newsletters

Latest Newsletters